Enanta Pharmaceuticals Inc (ENTA)
Sales/Maturities of Investments
$39.52M
Quarterly · Period ending: · USD
ENTA Sales/Maturities of Investments
Latest reported$39.52Mperiod ending
Latest reported$39.52Mperiod ending
ENTA Quarterly Sales/Maturities of Investments ($7.76M → $39.52M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
ENTA sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 39,522,000 | |
| 53,907,000 | |
| 101,469,000 | |
| 72,375,000 | |
| 59,664,000 | |
| 53,185,000 | |
| 77,648,000 | |
| 28,023,000 | |
| 95,346,000 | |
| 125,581,000 | |
| 134,515,000 | |
| 119,321,000 | |
| 33,049,999 | |
| 72,400,000 | |
| 104,100,000 | |
| 38,400,000 | |
| 54,554,000 | |
| 26,748,000 | |
| 108,766,000 | |
| 72,115,000 | |
| 93,057,000 | |
| 92,500,000 | |
| 87,417,000 | |
| 73,800,000 | |
| 122,755,000 | |
| 82,525,000 | |
| 80,748,000 | |
| 144,018,000 | |
| 69,053,000 | |
| 155,995,000 | |
| 98,999,000 | |
| 106,701,000 | |
| 48,995,000 | |
| 52,220,000 | |
| 52,766,000 | |
| 50,482,000 | |
| 43,348,000 | |
| 79,986,000 | |
| 75,489,000 | |
| 36,207,000 | |
| 35,115,000 | |
| 50,995,000 | |
| 31,187,000 | |
| 46,390,000 | |
| 28,325,000 | |
| 20,466,000 | |
| 15,436,000 | |
| 22,350,000 | |
| 34,243,000 | |
| 31,740,000 | |
| 11,594,000 | |
| 8,199,000 | |
| 6,380,000 | |
| 17,048,000 | |
| 15,651,000 | |
| 10,800,000 | |
| 3,850,000 | |
| 5,300,000 | |
| 8,750,000 | |
| 7,764,000 |